Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Linking VEGF deficiency and IL-33 upregulation in COPD.

Byers DE.

Am J Respir Cell Mol Biol. 2019 May 17. doi: 10.1165/rcmb.2019-0175ED. [Epub ahead of print] No abstract available.

PMID:
31100009
2.

Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid.

Tague LK, Byers DE, Hachem R, Kreisel D, Krupnick AS, Kulkarni HS, Chen C, Huang HJ, Gelman A.

Pharmacogenomics J. 2019 Apr 17. doi: 10.1038/s41397-019-0086-0. [Epub ahead of print]

PMID:
30992538
3.

Chest computed tomography imaging improves potential lung donor assessment.

Gauthier JM, Bierhals AJ, Liu J, Balsara KR, Frederiksen C, Gremminger E, Hachem RR, Witt CA, Trulock EP, Byers DE, Yusen RD, Aguilar PR, Marklin G, Nava RG, Kozower BD, Pasque MK, Meyers BF, Patterson GA, Kreisel D, Puri V.

J Thorac Cardiovasc Surg. 2019 Apr;157(4):1711-1718.e1. doi: 10.1016/j.jtcvs.2018.11.038. Epub 2018 Nov 24.

PMID:
30772037
4.

Association between Allosensitization and Waiting List Outcomes among Adult Lung Transplant Candidates in the United States.

Tague LK, Witt CA, Byers DE, Yusen RD, Aguilar PR, Kulkarni HS, Bain KB, Fester KA, Puri V, Kreisel D, Mohanakumar T, Trulock EP, Hachem RR.

Ann Am Thorac Soc. 2019 Feb 14. doi: 10.1513/AnnalsATS.201810-713OC. [Epub ahead of print]

PMID:
30763122
5.

Epithelial-Immune Cell Interactions for Drug Discovery in Chronic Obstructive Pulmonary Disease.

Keeler SP, Gerovac BJ, Wu K, Wang X, Chartock JR, Byers DE, Romero AG, Holtzman MJ.

Ann Am Thorac Soc. 2018 Dec;15(Supplement_4):S260-S265. doi: 10.1513/AnnalsATS.201808-531MG.

PMID:
30759005
6.

Technical Considerations for Lung Transplantation in Kartagener's Syndrome.

Gauthier JM, Takahashi T, Bierhals AJ, Brody SL, Hachem RR, Witt CA, Byers DE, Yusen RD, Trulock EP, Aguilar PR, Nava RG, Kozower BD, Meyers BF, Patterson GA, Kreisel D, Puri V.

Ann Thorac Surg. 2019 May;107(5):e337-e339. doi: 10.1016/j.athoracsur.2018.08.095. Epub 2018 Oct 26.

PMID:
30612988
7.

Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.

Kulkarni HS, Cherikh WS, Chambers DC, Garcia VC, Hachem RR, Kreisel D, Puri V, Kozower BD, Byers DE, Witt CA, Alexander-Brett J, Aguilar PR, Tague LK, Furuya Y, Patterson GA, Trulock EP 3rd, Yusen RD.

J Heart Lung Transplant. 2019 Jan;38(1):5-16. doi: 10.1016/j.healun.2018.09.016. Epub 2018 Sep 25.

PMID:
30391193
8.

Intracellular C3 Protects Human Airway Epithelial Cells from Stress-associated Cell Death.

Kulkarni HS, Elvington ML, Perng YC, Liszewski MK, Byers DE, Farkouh C, Yusen RD, Lenschow DJ, Brody SL, Atkinson JP.

Am J Respir Cell Mol Biol. 2019 Feb;60(2):144-157. doi: 10.1165/rcmb.2017-0405OC.

PMID:
30156437
9.

A single-center experience of 1500 lung transplant patients.

Balsara KR, Krupnick AS, Bell JM, Khiabani A, Scavuzzo M, Hachem R, Trulock E, Witt C, Byers DE, Yusen R, Meyers B, Kozower B, Patterson GA, Puri V, Kreisel D.

J Thorac Cardiovasc Surg. 2018 Aug;156(2):894-905.e3. doi: 10.1016/j.jtcvs.2018.03.112. Epub 2018 Apr 4.

PMID:
29891245
10.

The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort study.

Chen DL, Huang HJ, Byers DE, Shifren A, Belikoff B, Engle JT, Arentson E, Kemp D, Phillips S, Scherrer DE, Fujiwara H, Spayd KJ, Brooks FJ, Pierce RA, Castro M, Isakow W.

PLoS One. 2018 Feb 7;13(2):e0191783. doi: 10.1371/journal.pone.0191783. eCollection 2018.

11.

Acute graft-versus-host disease following lung transplantation in a patient with a novel TERT mutation.

Brestoff JR, Vessoni AT, Brenner KA, Uy GL, DiPersio JF, Blinder M, Witt CA, Byers DE, Hachem RR, Truclock EP, Early DS, Anadkat MJ, Musiek A, Javidan-Nejad C, Balfe DM, Rosman IS, Liu C, Zhang L, Despotis GJ, Ruzinova MB, Sehn JK, Amarillo I, Heusel JW, Swat W, Kim BS, Wartman LD, Yusen RD, Batista LFZ.

Thorax. 2018 May;73(5):489-492. doi: 10.1136/thoraxjnl-2017-211121. Epub 2018 Jan 30.

12.

Triggering Receptor Expressed on Myeloid Cells-2 Expression Tracks With M2-Like Macrophage Activity and Disease Severity in COPD.

Byers DE, Wu K, Dang-Vu G, Jin X, Agapov E, Zhang X, Battaile JT, Schechtman K, Yusen R, Pierce RA, Holtzman MJ.

Chest. 2018 Jan;153(1):77-86. doi: 10.1016/j.chest.2017.09.044. Epub 2017 Oct 7.

13.

The role of C4d deposition in the diagnosis of antibody-mediated rejection after lung transplantation.

Aguilar PR, Carpenter D, Ritter J, Yusen RD, Witt CA, Byers DE, Mohanakumar T, Kreisel D, Trulock EP, Hachem RR.

Am J Transplant. 2018 Apr;18(4):936-944. doi: 10.1111/ajt.14534. Epub 2017 Nov 11.

14.

Impact of Delayed Chest Closure on Surgical Site Infection After Lung Transplantation.

Aguilar PR, Bemiss BC, Witt C, Byers DE, Kreisel D, Puri V, Meyers B, Patterson GA, Krupnick AS, Yusen RD, Trulock EP, Hachem RR.

Ann Thorac Surg. 2017 Oct;104(4):1208-1214. doi: 10.1016/j.athoracsur.2017.05.023. Epub 2017 Aug 16.

PMID:
28821338
15.

PET-based Imaging of Chemokine Receptor 2 in Experimental and Disease-related Lung Inflammation.

Liu Y, Gunsten SP, Sultan DH, Luehmann HP, Zhao Y, Blackwell TS, Bollermann-Nowlis Z, Pan JH, Byers DE, Atkinson JJ, Kreisel D, Holtzman MJ, Gropler RJ, Combadiere C, Brody SL.

Radiology. 2017 Jun;283(3):758-768. doi: 10.1148/radiol.2016161409. Epub 2017 Jan 3.

16.

Significant Interference in Mass Cytometry from Medicinal Iodine in Human Lung.

Keller BC, Presti RM, Byers DE, Atkinson JJ.

Am J Respir Cell Mol Biol. 2016 Jul;55(1):150-1. doi: 10.1165/rcmb.2015-0403LE. No abstract available.

17.

Hyperammonemia Syndrome After Lung Transplantation: A Single Center Experience.

Chen C, Bain KB, Iuppa JA, Yusen RD, Byers DE, Patterson GA, Trulock EP, Hachem RR, Witt CA.

Transplantation. 2016 Mar;100(3):678-84. doi: 10.1097/TP.0000000000000868.

PMID:
26335916
18.

The impact of pre-transplant allosensitization on outcomes after lung transplantation.

Bosanquet JP, Witt CA, Bemiss BC, Byers DE, Yusen RD, Patterson AG, Kreisel D, Mohanakumar T, Trulock EP, Hachem RR.

J Heart Lung Transplant. 2015 Nov;34(11):1415-22. doi: 10.1016/j.healun.2015.06.003. Epub 2015 Jun 10.

19.

TREM-2 promotes macrophage survival and lung disease after respiratory viral infection.

Wu K, Byers DE, Jin X, Agapov E, Alexander-Brett J, Patel AC, Cella M, Gilfilan S, Colonna M, Kober DL, Brett TJ, Holtzman MJ.

J Exp Med. 2015 May 4;212(5):681-97. doi: 10.1084/jem.20141732. Epub 2015 Apr 20.

20.

OSCAR is a receptor for surfactant protein D that activates TNF-α release from human CCR2+ inflammatory monocytes.

Barrow AD, Palarasah Y, Bugatti M, Holehouse AS, Byers DE, Holtzman MJ, Vermi W, Skjødt K, Crouch E, Colonna M.

J Immunol. 2015 Apr 1;194(7):3317-26. doi: 10.4049/jimmunol.1402289. Epub 2015 Feb 25.

21.

Linking acute infection to chronic lung disease. The role of IL-33-expressing epithelial progenitor cells.

Holtzman MJ, Byers DE, Brett JA, Patel AC, Agapov E, Jin X, Wu K.

Ann Am Thorac Soc. 2014 Dec;11 Suppl 5:S287-91. doi: 10.1513/AnnalsATS.201402-056AW. Review.

22.

Imaging pulmonary inducible nitric oxide synthase expression with PET.

Huang HJ, Isakow W, Byers DE, Engle JT, Griffin EA, Kemp D, Brody SL, Gropler RJ, Miller JP, Chu W, Zhou D, Pierce RA, Castro M, Mach RH, Chen DL.

J Nucl Med. 2015 Jan;56(1):76-81. doi: 10.2967/jnumed.114.146381. Epub 2014 Dec 18.

23.

Defining the roles of IL-33, thymic stromal lymphopoietin, and IL-25 in human asthma.

Byers DE.

Am J Respir Crit Care Med. 2014 Oct 1;190(7):715-6. doi: 10.1164/rccm.201408-1539ED. No abstract available.

24.

The role of airway epithelial cells and innate immune cells in chronic respiratory disease.

Holtzman MJ, Byers DE, Alexander-Brett J, Wang X.

Nat Rev Immunol. 2014 Oct;14(10):686-98. doi: 10.1038/nri3739. Epub 2014 Sep 19. Review.

25.

Interferon response and respiratory virus control are preserved in bronchial epithelial cells in asthma.

Patel DA, You Y, Huang G, Byers DE, Kim HJ, Agapov E, Moore ML, Peebles RS Jr, Castro M, Sumino K, Shifren A, Brody SL, Holtzman MJ.

J Allergy Clin Immunol. 2014 Dec;134(6):1402-1412.e7. doi: 10.1016/j.jaci.2014.07.013. Epub 2014 Sep 9.

26.

Myb permits multilineage airway epithelial cell differentiation.

Pan JH, Adair-Kirk TL, Patel AC, Huang T, Yozamp NS, Xu J, Reddy EP, Byers DE, Pierce RA, Holtzman MJ, Brody SL.

Stem Cells. 2014 Dec;32(12):3245-56. doi: 10.1002/stem.1814.

27.

Acute antibody-mediated rejection after lung transplantation.

Witt CA, Gaut JP, Yusen RD, Byers DE, Iuppa JA, Bennett Bain K, Alexander Patterson G, Mohanakumar T, Trulock EP, Hachem RR.

J Heart Lung Transplant. 2013 Oct;32(10):1034-40. doi: 10.1016/j.healun.2013.07.004. Epub 2013 Aug 13.

28.

Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease.

Byers DE, Alexander-Brett J, Patel AC, Agapov E, Dang-Vu G, Jin X, Wu K, You Y, Alevy Y, Girard JP, Stappenbeck TS, Patterson GA, Pierce RA, Brody SL, Holtzman MJ.

J Clin Invest. 2013 Sep;123(9):3967-82. doi: 10.1172/JCI65570. Epub 2013 Aug 15. Erratum in: J Clin Invest. 2013 Dec 2;123(12):5410.

29.

IL-13-induced airway mucus production is attenuated by MAPK13 inhibition.

Alevy YG, Patel AC, Romero AG, Patel DA, Tucker J, Roswit WT, Miller CA, Heier RF, Byers DE, Brett TJ, Holtzman MJ.

J Clin Invest. 2012 Dec;122(12):4555-68. doi: 10.1172/JCI64896. Epub 2012 Nov 26.

30.

Alternatively activated macrophages and airway disease.

Byers DE, Holtzman MJ.

Chest. 2011 Sep;140(3):768-774. doi: 10.1378/chest.10-2132. Review.

31.

Alternatively activated macrophages as cause or effect in airway disease.

Byers DE, Holtzman MJ.

Am J Respir Cell Mol Biol. 2010 Jul;43(1):1-4. doi: 10.1165/rcmb.2009-0407ED. No abstract available.

PMID:
20587775
32.

Immune pathways for translating viral infection into chronic airway disease.

Holtzman MJ, Byers DE, Benoit LA, Battaile JT, You Y, Agapov E, Park C, Grayson MH, Kim EY, Patel AC.

Adv Immunol. 2009;102:245-76. doi: 10.1016/S0065-2776(09)01205-X. Review.

33.

Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease.

Kim EY, Battaile JT, Patel AC, You Y, Agapov E, Grayson MH, Benoit LA, Byers DE, Alevy Y, Tucker J, Swanson S, Tidwell R, Tyner JW, Morton JD, Castro M, Polineni D, Patterson GA, Schwendener RA, Allard JD, Peltz G, Holtzman MJ.

Nat Med. 2008 Jun;14(6):633-40. doi: 10.1038/nm1770. Epub 2008 May 18.

34.
35.

H2-M3 presents a nonformylated viral epitope to CTLs generated in vitro.

Byers DE, Fischer Lindahl K.

J Immunol. 1998 Jul 1;161(1):90-6.

36.

H2-M3, a full-service class Ib histocompatibility antigen.

Lindahl KF, Byers DE, Dabhi VM, Hovik R, Jones EP, Smith GP, Wang CR, Xiao H, Yoshino M.

Annu Rev Immunol. 1997;15:851-79. Review.

PMID:
9143709
37.

The evolution of red blood cell and lymphocyte Ro/SSA.

Byers DE, Itoh Y, Reichlin M.

Autoimmunity. 1990;7(2-3):121-8.

PMID:
1716477

Supplemental Content

Loading ...
Support Center